Introduction

Exciting advancements in minimally invasive glaucoma surgery (MIGS) were front and center at this year's American Academy of Ophthalmology (AAO) meeting in Chicago, with insights shared by renowned glaucoma specialist Dr. Brian Francis from the Doheny Eye Institute and the UCLA Department of Ophthalmology.

Presentation Highlights

In a comprehensive presentation, Dr. Francis and his team spotlighted the latest FDA-approved MIGS techniques, emphasizing the importance of hands-on learning through skill transfer labs designed for both novice and seasoned ophthalmologists. "We have consolidated all the currently available MIGS techniques under one roof, enabling attendees to engage directly with each procedure and decide which may suit their practice best," Dr. Francis explained.

Course Structure and Learning Opportunities

The course featured an exciting mix of didactic sessions and practical labs, offering opportunities for participants to interact with cutting-edge devices from leading manufacturers. This structure is essential for continual learning—a necessity in the ever-evolving field of glaucoma surgery. "Surgeons need to continuously evolve their practice and skills. This meeting is pivotal for bringing the latest knowledge and technologies back to their own patients," noted Dr. Francis.

Technologies Showcased

Among the technologies showcased were trabecular micro bypass stents, including EyeStent and Hydrus. Attendees also explored techniques like ab interno goniotomy and visco dilation with innovative tools such as the Kahook Dual Blade, Streamline, and Omnitrab. In a game-changing development, the labs introduced the Ion Trek CyclopentalloFlow procedure, which marks a significant return to the suprachoroidal outflow space.

Inclusivity in Education

What makes this event particularly special is its ability to cater not only to newcomers in the field but also to experienced specialists looking to enhance their treatment repertoire. "We've designed this course to serve everyone—from those just starting in MIGS to experts eager to expand their skill set," Dr. Francis stated.

The Future of MIGS

The momentum surrounding MIGS is palpable as it continues to reshape the landscape of glaucoma treatment with its promise of less invasive, yet highly effective, surgical options. With ongoing innovation and educational initiatives, the future of glaucoma care looks brighter than ever. Don't miss the opportunity to catch the latest trends and techniques that can elevate your practice—stay tuned for what's next in the world of minimally invasive surgery!